Exemestane Compared With Tamoxifen in Treating Women With Locally Recurrent or Metastatic Breast Cancer
Completed
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1996-05-01
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
exemestane or tamoxifen may fight cancer by blocking the uptake of estrogen.
PURPOSE: Randomized phase II/III trial to compare the effectiveness of exemestane with that
of tamoxifen in treating postmenopausal women who have locally recurrent or metastatic breast
cancer.
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Unknown status
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
1998-02-01
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
exemestane or tamoxifen may fight breast cancer by blocking the uptake of estrogen. It is not
yet known whether exemestane is more effective than tamoxifen in treating breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of exemestane with that of
tamoxifen in treating postmenopausal women with primary breast cancer who have already
received 2-3 years of tamoxifen following surgery.
Exemestane Compared With Tamoxifen in Treating Postmenopausal Women With Primary Breast Cancer
Unknown status
UNICANCER
Phase 3
1998-02-01
RATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using
exemestane or tamoxifen may fight breast cancer by blocking the uptake of estrogen. It is not
yet known whether exemestane is more effective than tamoxifen in treating breast cancer.
PURPOSE: Randomized phase III trial to compare the effectiveness of exemestane with that of
tamoxifen in treating postmenopausal women with primary breast cancer who have already
received 2-3 years of tamoxifen following surgery.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
